These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2107075)

  • 1. Extinction of Ig genes expression in myeloma x fibroblast somatic cell hybrids is accompanied by repression of the oct-2 gene encoding a B-cell specific transcription factor.
    Bergman Y; Strich B; Sharir H; Ber R; Laskov R
    EMBO J; 1990 Mar; 9(3):849-55. PubMed ID: 2107075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma X fibroblast somatic cell hybrids.
    Reich L; Sharir H; Ber R; Wirth T; Bergman Y; Laskov R
    Somat Cell Mol Genet; 1996 Jan; 22(1):1-20. PubMed ID: 8643990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extinction of an immunoglobulin kappa promoter in cell hybrids is mediated by the octamer motif and correlates with suppression of Oct-2 expression.
    Junker S; Pedersen S; Schreiber E; Matthias P
    Cell; 1990 May; 61(3):467-74. PubMed ID: 2110507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both immunoglobulin promoter and enhancer sequences are targets for suppression in myeloma-fibroblast hybrid cells.
    Junker S; Nielsen V; Matthias P; Picard D
    EMBO J; 1988 Oct; 7(10):3093-8. PubMed ID: 3141146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc.
    Thøger Andersen AS; Jensen AW; Grant P; Arulampalam V; Pettersson S; Junker S
    Mol Immunol; 1997 Feb; 34(2):97-107. PubMed ID: 9188842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
    Elmaleh N; Matthias P; Schaffner W
    Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription.
    Atchison ML; Perry RP
    EMBO J; 1988 Dec; 7(13):4213-20. PubMed ID: 2854057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extinction of immunoglobulin gene expression in B cells upon fusion with HeLa cells is preceded by rapid nuclear depletion of essential transcription factors and is accompanied by widespread inactivation of genes expressed in a B cell-specific manner.
    Junker S; Lamm M; Nielsen V; Matthias P
    J Cell Sci; 1997 Oct; 110 ( Pt 20)():2579-87. PubMed ID: 9372447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes containing the IgH enhancer in non-lymphoid cells.
    Klein BY; Morrison SL
    Mol Immunol; 1990 Aug; 27(8):713-22. PubMed ID: 2119478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin V kappa promoter.
    Atchison ML; Delmas V; Perry RP
    EMBO J; 1990 Oct; 9(10):3109-17. PubMed ID: 2120037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extinction of Oct-3/4 gene expression in embryonal carcinoma x fibroblast somatic cell hybrids is accompanied by changes in the methylation status, chromatin structure, and transcriptional activity of the Oct-3/4 upstream region.
    Ben-Shushan E; Pikarsky E; Klar A; Bergman Y
    Mol Cell Biol; 1993 Feb; 13(2):891-901. PubMed ID: 7678695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate silencing of myeloma-specific genes in myeloma x T lymphoma hybrids.
    Lieberman SA; Hines MD; Bergsagel PL; Kuehl WM; Eckhardt LA
    J Immunol; 1993 Sep; 151(5):2588-600. PubMed ID: 8360480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.
    Shah PC; Bertolino E; Singh H
    EMBO J; 1997 Dec; 16(23):7105-17. PubMed ID: 9384588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids.
    Radomska HS; Shen CP; Kadesch T; Eckhardt LA
    Immunity; 1994 Nov; 1(8):623-34. PubMed ID: 7600290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
    Singh H; Sen R; Baltimore D; Sharp PA
    Nature; 1986 Jan 9-15; 319(6049):154-8. PubMed ID: 3079885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
    Laurencikiene J; Deveikaite V; Severinson E
    J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II.
    Raschke EE; Albert T; Eick D
    J Immunol; 1999 Oct; 163(8):4375-82. PubMed ID: 10510378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.
    Currie RA; Roeder RG
    Mol Cell Biol; 1989 Oct; 9(10):4239-47. PubMed ID: 2511430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extinction of expression of the translocated myc gene in somatic cell hybrids between mouse myeloma and L-cells.
    Greenberg A; Hijazzi M; Sharir H; Cohen L; Bergman Y; Ber R; Laskov R
    Int J Cancer; 1989 Jan; 43(1):87-92. PubMed ID: 2492015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.